Smith T - Search Results

1

Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia.

Kantarjian HM, Smith T, Estey E, Polyzos A, O'Brien S, Pierce S, Beran M, Feldman E, Keating MJ. Kantarjian HM, et al. Among authors: smith t. Am J Med. 1992 Dec;93(6):599-604. doi: 10.1016/0002-9343(92)90191-d. Am J Med. 1992. PMID: 1466355

2

Comparison of results of salvage therapy in adult acute myelogenous leukemia.

Keating MJ, Estey E, Kantarjian HM, Walters R, Smith T, McCredie KB, Freireich EJ. Keating MJ, et al. Among authors: smith t. Acta Haematol. 1987;78 Suppl 1:120-6. doi: 10.1159/000205916. Acta Haematol. 1987. PMID: 3124434

3

Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen.

Kantarjian HM, O'Brien S, Smith T, Estey EH, Beran M, Preti A, Pierce S, Keating MJ. Kantarjian HM, et al. Among authors: smith t. Br J Haematol. 1994 Sep;88(1):94-100. doi: 10.1111/j.1365-2141.1994.tb04982.x. Br J Haematol. 1994. PMID: 7803263

4

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

O'Brien S, Kantarjian H, Beran M, Smith T, Koller C, Estey E, Robertson LE, Lerner S, Keating M. O'Brien S, et al. Among authors: smith t. Blood. 1993 Sep 15;82(6):1695-700. Blood. 1993. PMID: 8400226 Free article. Clinical Trial.

5

Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.

Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M, Koller C, Kornblau S, O'Brien S, Andreeff M. Sarris A, et al. Among authors: smith t. Leuk Lymphoma. 1996 Mar;21(1-2):85-92. doi: 10.3109/10428199609067584. Leuk Lymphoma. 1996. PMID: 8907274

6

Determinants of prognosis in late chronic-phase chronic myelogenous leukemia.

Rodriguez J, Cortes J, Smith T, O'Brien S, Rios MB, Talpaz M, Kantarjian H. Rodriguez J, et al. Among authors: smith t. J Clin Oncol. 1998 Dec;16(12):3782-7. doi: 10.1200/JCO.1998.16.12.3782. J Clin Oncol. 1998. PMID: 9850022

7

Response to therapy is independently associated with survival prolongation in chronic myelogenous leukemia in the blastic phase.

Kantarjian HM, Shan J, Smith T, Talpaz M, Kozuch P, Rios MB, Cortes J, Giles FJ, O'Brien S. Kantarjian HM, et al. Among authors: smith t. Cancer. 2001 Nov 15;92(10):2501-7. doi: 10.1002/1097-0142(20011115)92:10<2501::aid-cncr1600>3.0.co;2-n. Cancer. 2001. PMID: 11745182

8

Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two.

Estey E, Maksymiuk A, Smith T, Fainstein V, Keating M, McCredie KB, Freireich EJ, Bodey GP. Estey E, et al. Among authors: smith t. Arch Intern Med. 1984 Aug;144(8):1562-8. doi: 10.1001/archinte.144.8.1562. Arch Intern Med. 1984. PMID: 6087753 Clinical Trial.

9

Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia.

Keating MJ, Cork A, Broach Y, Smith T, Walters RS, McCredie KB, Trujillo J, Freireich EJ. Keating MJ, et al. Among authors: smith t. Leuk Res. 1987;11(2):119-33. doi: 10.1016/0145-2126(87)90017-8. Leuk Res. 1987. PMID: 3469482

10

Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia.

Kantarjian HM, Vellekoop L, McCredie KB, Keating MJ, Hester J, Smith T, Barlogie B, Trujillo J, Freireich EJ. Kantarjian HM, et al. Among authors: smith t. J Clin Oncol. 1985 Feb;3(2):192-200. doi: 10.1200/JCO.1985.3.2.192. J Clin Oncol. 1985. PMID: 3855444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,213 results

Search Page

Filters